Published in Int Ophthalmol Clin on January 01, 2017
Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (2009) 9.84
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition (1992) 6.77
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02
The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr (1986) 4.81
Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Prevalence of dry eye among the elderly. Am J Ophthalmol (1997) 3.23
Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci (2004) 3.22
Aging and proinflammatory cytokines. Curr Opin Hematol (2001) 3.05
Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr (2000) 2.92
Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell (2008) 2.87
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology (2000) 2.74
Utility assessment among patients with dry eye disease. Ophthalmology (2003) 2.71
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Prevalence of ocular surface disease in glaucoma patients. J Glaucoma (2008) 2.65
The epidemiology of dry eye in Melbourne, Australia. Ophthalmology (1998) 2.58
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol (2006) 2.33
Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol (1999) 2.28
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res (2006) 2.27
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci (2002) 2.19
Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci (1999) 2.16
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci (2007) 2.09
Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun (2014) 1.96
Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea (2009) 1.96
Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol (2005) 1.96
Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med (1999) 1.95
Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology (1997) 1.89
Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care (2008) 1.89
Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metab (2007) 1.85
Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology (2008) 1.84
IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol (2007) 1.82
Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol (2002) 1.81
Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci (2007) 1.78
Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci (2009) 1.75
Incidence of dry eye in an older population. Arch Ophthalmol (2004) 1.74
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci (2000) 1.74
A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci (2002) 1.73
Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One (2012) 1.64
Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci (2006) 1.63
Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol (1979) 1.62
Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand (2000) 1.61
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum (2002) 1.61
Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis (2010) 1.54
Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev (2004) 1.50
Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci (2002) 1.48
Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea (2007) 1.46
Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci (2006) 1.46
A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol (2004) 1.46
Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol (2003) 1.45
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology (2000) 1.39
Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol (2000) 1.39
Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol (2011) 1.32
Alterations of ocular surface gene expression in Sjögren's syndrome. Adv Exp Med Biol (1998) 1.30
Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest Ophthalmol (1975) 1.29
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol (2010) 1.29
Utility assessment to measure the impact of dry eye disease. Ocul Surf (2006) 1.27
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26
Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci (1994) 1.26
Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci (2009) 1.25
Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea (1992) 1.25
Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea (2003) 1.23
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol (2008) 1.23
Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol (2010) 1.22
Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res (2005) 1.21
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci (2001) 1.20
Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci (2009) 1.20
Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease. Invest Ophthalmol Vis Sci (2008) 1.20
Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology (1995) 1.19
Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev (2000) 1.17
Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci (2000) 1.15
Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol (2008) 1.15
Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology (2000) 1.14
Stress responses and innate immunity: aging as a contributory factor. Aging Cell (2004) 1.14
Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell Signal (2004) 1.14
Anatomy and histopathology of human meibomian gland. Cornea (2002) 1.14
Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol (2010) 1.13
Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol (2014) 1.12
Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol (2011) 1.12
Age-related changes in the meibomian gland. Exp Eye Res (2009) 1.10
Association between meibomian gland changes and aging, sex, or tear function. Cornea (2006) 1.10
CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders. J Allergy Clin Immunol (2005) 1.09
Desiccating stress induces CD4+ T-cell-mediated Sjögren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γ. Am J Pathol (2011) 1.07
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study. Ophthalmology (2013) 1.05
Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea (2005) 1.05
Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci (2013) 1.04
The aging lacrimal gland: changes in structure and function. Ocul Surf (2008) 1.04
Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China. Cornea (2008) 1.04
Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension. Eur J Ophthalmol (2012) 1.04
Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. Am J Pathol (2012) 1.03
The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc (2008) 1.03
Entrapment of conjunctival goblet cells by desiccation-induced cornification. Invest Ophthalmol Vis Sci (2011) 1.03
Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. Exp Eye Res (2003) 1.02
Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica (1999) 1.02
NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One (2012) 1.02
Dry eye in the elderly. Drugs Aging (2001) 1.01
Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells (2004) 2.73
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Phenotypic characterization of human corneal epithelial cells expanded ex vivo from limbal explant and single cell cultures. Exp Eye Res (2004) 2.02
Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol (2005) 1.96
Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci (2009) 1.75
Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci (2010) 1.29
Epithelial-immune cell interaction in dry eye. Cornea (2008) 1.27
Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions. Mol Vis (2007) 1.11
Partial enrichment of a population of human limbal epithelial cells with putative stem cell properties based on collagen type IV adhesiveness. Exp Eye Res (2005) 1.09
T helper cytokines in dry eye disease. Exp Eye Res (2013) 0.97
TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci (2010) 0.96
Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci (2013) 0.91
Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf (2005) 0.91
Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease. PLoS One (2013) 0.91
A putative role for RHAMM/HMMR as a negative marker of stem cell-containing population of human limbal epithelial cells. Stem Cells (2008) 0.89
Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res Ther (2012) 0.85
Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress. J Leukoc Biol (2013) 0.84
Glial cell-derived neurotrophic factor gene delivery enhances survival of human corneal epithelium in culture and the overexpression of GDNF in bioengineered constructs. Exp Eye Res (2008) 0.83
Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas. Invest Ophthalmol Vis Sci (2015) 0.81
Macrophage Phenotype in the Ocular Surface of Experimental Murine Dry Eye Disease. Arch Immunol Ther Exp (Warsz) (2015) 0.77